Lowered allowed returns across its UK and Australian regulated assets since 2018 have eaten into earnings growth and investment returns for CKI. The cut in the regulator's benchmark cost of equity is ...
Simon Wilson's CEO appointment, share buybacks, and increased investment income signal growth opportunities for Markel ...
Acadia Healthcare shares remain undervalued yet unsuitable for stable portfolios. Read here to know why we reiterate a hold ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback